P.D.H Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer - P.D.H Group · Pakistan
P.D.H Group pharmaceutical manufacturing entity with a long-standing Pakistan healthcare legacy and established tablet and syrup manufacturing operations.
P.D.H Pharmaceuticals products in Pakistan
P.D.H Pharmaceuticals (Pvt) Ltd has 48 medicine presentations registered in Pakistan under 34 brands, covering 28 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and CNS & mental health. Its brands with the most registered strengths and packs are Rispon (Risperidone), Endleat (Enalapril), Oxalizid (Linezolid) and Colitran (Sulfamethoxazole + Trimethoprim, Sulfamethoxazole). 48 products have an official DRAP price on MedInfoBase. See all 34 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- P.D.H Pharmaceuticals (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer - P.D.H Group
- Website
- pdhhealthcare.com ↗
- Phone
- +923234007122
- Official contact
- Contact page ↗
- Corporate source details checked
- 21 Aug 2026
- Corporate profile completeness
- 88%
Company location
No exact premises location is published without a defensible source.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where P.D.H Pharmaceuticals (Pvt) Ltd is priced against the market
41 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Anamol | Paracetamol | 120 mg/5 mL | Suspension | 60ml | 002285 | PKR 66.01 | PKR 1.10/mL | 🔒 Pharma Pro |
| Atropine | Atropine | 10 mg/10 mL | Ophthalmic drops | 10ml | 002279 | PKR 62.55 | PKR 6.26/mL | No comparator |
| Ceflorex | Cefixime | 100 mg/5 mL | Suspension | 30ml | 028052 | PKR 290.67 | PKR 9.69/mL | 🔒 Pharma Pro |
| CeflorexSource observed | Cefixime | 400 mg | Capsule | 5's | 028053Official source ↗ | No indexed price | — | — |
| Ceflorex D.S | Cefixime | 200 mg/5 mL | Suspension | 30ml | 038415 | PKR 307.45 | PKR 10.25/mL | 🔒 Pharma Pro |
| Coagnor | Warfarin | 5 mg | Tablet | 10 x 10's | 044697 | PKR 802.79 | PKR 8.03/tablet | 🔒 Pharma Pro |
| Colitran | Sulfamethoxazole + Trimethoprim | 200 mg + 40 mg/5 mL | Suspension | 50ml | 005540 | PKR 28.26 | PKR 0.57/mL | 🔒 Pharma Pro |
| Colitran | Sulfamethoxazole | 80 mg | Tablet | 200's | 005541 | PKR 522.03 | PKR 2.61/tablet | No comparator |
| Colitran DS | Sulfamethoxazole | 160 mg | Tablet | 10x10's | 008541 | PKR 432.91 | PKR 4.33/tablet | 🔒 Pharma Pro |
| Dextrosol | Sodium chloride | 2.6 g | Sachet | 20's | 007117 | PKR 521.15 | PKR 26.06/sachet | 🔒 Pharma Pro |
| Dextrosol | Oral rehydration salts (ORS) | NaCl 2.6 g + Na citrate 2.9 g + KCl 1.5 g + Glucose 13.6 g | Sachet | 1's | 007117 | PKR 26.64 | PKR 26.64/sachet | No comparator |
| Dulam | Lamivudine | 100 mg | Tablet | 14's | 038351 | PKR 683.23 | PKR 48.80/tablet | 🔒 Pharma Pro |
| Endleat | Enalapril | 10 mg | Tablet | 2 x 10's | 040968 | PKR 112.73 | PKR 5.64/tablet | 🔒 Pharma Pro |
| Endleat | Enalapril | 20 mg | Tablet | 2 x 10's | 040991 | PKR 384.32 | PKR 19.22/tablet | 🔒 Pharma Pro |
| Endleat | Enalapril | 5 mg | Tablet | 2 x 10's | 040992 | PKR 93.94 | PKR 4.70/tablet | 🔒 Pharma Pro |
| Floraclean | Clotrimazole | 100 mg | Vaginal tablet | 1 x 6's | 029344 | PKR 102.48 | PKR 17.08/tablet | 🔒 Pharma Pro |
| Floraclean | Clotrimazole | 500 mg | Vaginal tablet | 1's | 029345 | PKR 153.73 | PKR 153.73/tablet | 🔒 Pharma Pro |
| Giozar | Losartan | 50 mg | Tablet | 2x10's | 028928 | PKR 484.03 | PKR 24.20/tablet | 🔒 Pharma Pro |
| Hynowell | Midazolam | 7.5 mg | Tablet | 10's | 025872 | PKR 68.32 | PKR 6.83/tablet | 🔒 Pharma Pro |
| Ibumid | Ibuprofen | 100 mg/5 mL | Suspension | 90ml | 016432 | PKR 75.11 | PKR 0.83/mL | 🔒 Pharma Pro |
| Ibumid | Ibuprofen | 600 mg | Tablet | 24's | 016433 | PKR 122.98 | PKR 5.12/tablet | 🔒 Pharma Pro |
| Indralol | Timolol | 0.5 % | Ophthalmic drops | 5 ml | 040970 | PKR 153.73 | PKR 30.75/mL | 🔒 Pharma Pro |
| Kuin | Ciprofloxacin | 250 mg | Tablet | 10's | 030506 | PKR 204.97 | PKR 20.50/tablet | 🔒 Pharma Pro |
| KuinSource observed | Ciprofloxacin | 500 mg | Tablet | 10's | 030507Official source ↗ | No indexed price | — | — |
| KuinSource observed | Ciprofloxacin | 500 mg | Tablet | 200's | 030507Official source ↗ | No indexed price | — | — |
| kuinkid | Ciprofloxacin | 125 mg/5 mL | Suspension | 60ml | 103636 | PKR 215.59 | PKR 3.59/mL | 🔒 Pharma Pro |
| kuinkid | Ciprofloxacin | 250 mg/5 mL | Suspension | 60ml | 103637 | PKR 211.24 | PKR 3.52/mL | 🔒 Pharma Pro |
| Kuinopt | Ciprofloxacin | 3.5 mg/mL | Ophthalmic drops | 5ml | 025600 | PKR 163.98 | PKR 32.80/mL | No comparator |
| Laxilose | Lactulose | 3.35 g/5 mL | Syrup | 120ml | 029343 | PKR 252.79 | PKR 2.11/mL | 🔒 Pharma Pro |
| Leeway | Clopidogrel | 75 mg | Tablet | 1 x 10's | 034840 | PKR 239.13 | PKR 23.91/tablet | 🔒 Pharma Pro |
| Lioponorm | Simvastatin | 10 mg | Tablet | 1x 10's | 029731 | PKR 290.37 | PKR 29.04/tablet | 🔒 Pharma Pro |
| Lioponorm | Simvastatin | 20 mg | Tablet | 1x 10's | 029732 | PKR 397.46 | PKR 39.75/tablet | 🔒 Pharma Pro |
| Myclar | Clarithromycin | 125 mg/5 mL | Suspension | 60ml | 029335 | PKR 427.02 | PKR 7.12/mL | 🔒 Pharma Pro |
| Myclar XL | Clarithromycin | 500 mg | Tablet | 1x5's | 029336 | PKR 469.72 | PKR 93.94/tablet | 🔒 Pharma Pro |
| Neophenicol | Chloramphenicol | 125 mg/5 mL | Suspension | 60ml, | 001901 | PKR 62.74 | — | No comparator |
| Omecer | Omeprazole | 20 mg | Capsule | 14's | 018610 | PKR 871.99 | PKR 62.29/capsule | 🔒 Pharma Pro |
| Oxalizid | Linezolid | 400 mg | Tablet | 12's | 101650 | PKR 2,062.50 | PKR 171.88/tablet | 🔒 Pharma Pro |
| Oxalizid | Linezolid | 600 mg | Tablet | 12's | 101651 | PKR 3,610.78 | PKR 300.90/tablet | 🔒 Pharma Pro |
| Oxalizid | Linezolid | 100 mg/5 mL | Dry suspension | 60ml | 101652 | PKR 494.43 | PKR 8.24/mL | 🔒 Pharma Pro |
| PARACETAMOL | Paracetamol | 500 mg | Tablet | 20 x 10's | 002278 | PKR 762.93 | PKR 3.81/tablet | 🔒 Pharma Pro |
| Pilocarpine 1% | Pilocarpine | 1 % | Ophthalmic drops | 15ml | 002280 | PKR 76.22 | PKR 5.08/mL | No comparator |
| Pilocarpine 2% | Pilocarpine | 2 % | Ophthalmic drops | 15ml | 002281 | PKR 88.42 | PKR 5.89/mL | 🔒 Pharma Pro |
| Pilocarpine 4% | Pilocarpine | 4 % | Ophthalmic drops | 15ml | 002282 | PKR 112.82 | PKR 7.52/mL | No comparator |
| Predace | Prednisolone | 10 mg/mL | Ophthalmic drops | 5 ml | 040988 | PKR 85.40 | PKR 17.08/mL | 🔒 Pharma Pro |
| Quest | Levofloxacin | 250 mg | Tablet | 1 x 10's | 029341 | PKR 444.10 | PKR 44.41/tablet | 🔒 Pharma Pro |
| Quest | Levofloxacin | 500 mg | Tablet | 1 x 10's | 029342 | PKR 717.39 | PKR 71.74/tablet | 🔒 Pharma Pro |
| Rispon | Risperidone | 1 mg | Tablet | 10's | 035829 | PKR 204.97 | PKR 20.50/tablet | 🔒 Pharma Pro |
| Rispon | Risperidone | 2 mg | Tablet | 10's | 035830 | PKR 333.07 | PKR 33.31/tablet | 🔒 Pharma Pro |
| Rispon | Risperidone | 3 mg | Tablet | 10's | 035831 | PKR 512.42 | PKR 51.24/tablet | 🔒 Pharma Pro |
| Rispon | Risperidone | 4 mg | Tablet | 10's | 035832 | PKR 666.15 | PKR 66.62/tablet | 🔒 Pharma Pro |
All 34 P.D.H Pharmaceuticals brands in Pakistan
- Anamol Paracetamol · 120 mg/5 mL suspension
- Atropine Atropine · 10 mg/10 mL drops
- Ceflorex Cefixime · 100 mg/5 mL suspension
- Ceflorex D.S Cefixime · 200 mg/5 mL suspension
- Coagnor Warfarin · 5 mg tablet
- Colitran Sulfamethoxazole + Trimethoprim, Sulfamethoxazole · 200 mg + 40 mg/5 mL suspension, 80 mg tablet
- Colitran DS Sulfamethoxazole · 160 mg tablet
- Dextrosol Sodium chloride, Oral rehydration salts (ORS) · 2.6 g sachet, NaCl 2.6 g + Na citrate 2.9 g + KCl 1.5 g + Glucose 13.6 g sachet
- Dulam Lamivudine · 100 mg tablet
- Endleat Enalapril · 10 mg tablet, 20 mg tablet, 5 mg tablet
- Floraclean Clotrimazole · 100 mg pessary, 500 mg pessary
- Giozar Losartan · 50 mg tablet
- Hynowell Midazolam · 7.5 mg tablet
- Ibumid Ibuprofen · 100 mg/5 mL suspension, 600 mg tablet
- Indralol Timolol · 0.5 % drops
- Kuin Ciprofloxacin · 250 mg tablet
- kuinkid Ciprofloxacin · 125 mg/5 mL suspension, 250 mg/5 mL suspension
- Kuinopt Ciprofloxacin · 3.5 mg/mL drops
- Laxilose Lactulose · 3.35 g/5 mL syrup
- Leeway Clopidogrel · 75 mg tablet
- Lioponorm Simvastatin · 10 mg tablet, 20 mg tablet
- Myclar Clarithromycin · 125 mg/5 mL suspension
- Myclar XL Clarithromycin · 500 mg tablet
- Neophenicol Chloramphenicol · 125 mg/5 mL suspension
- Omecer Omeprazole · 20 mg capsule
- Oxalizid Linezolid · 100 mg/5 mL suspension, 400 mg tablet, 600 mg tablet
- PARACETAMOL Paracetamol · 500 mg tablet
- Pilocarpine 1% Pilocarpine · 1 % drops
- Pilocarpine 2% Pilocarpine · 2 % drops
- Pilocarpine 4% Pilocarpine · 4 % drops
- Predace Prednisolone · 10 mg/mL drops
- Quest Levofloxacin · 250 mg tablet, 500 mg tablet
- Rispon Risperidone · 1 mg tablet, 2 mg tablet, 3 mg tablet
- Tropide Tropicamide · 1 % drops
P.D.H Pharmaceuticals: common questions
How many products does P.D.H Pharmaceuticals have in Pakistan?
P.D.H Pharmaceuticals (Pvt) Ltd has 48 registered medicine presentations in Pakistan, sold under 34 brands and covering 28 generic medicines.
What are the main brands of P.D.H Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Rispon (Risperidone), Endleat (Enalapril), Oxalizid (Linezolid), Colitran (Sulfamethoxazole + Trimethoprim, Sulfamethoxazole) and Dextrosol (Sodium chloride, Oral rehydration salts (ORS)). This is not a sales ranking.
Which therapy areas does P.D.H Pharmaceuticals cover?
The most products are in Anti-infectives (20), Cardiovascular (6), CNS & mental health (5), Ophthalmology (5) and Pain & musculoskeletal (4).
Where can I see P.D.H Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.